Why does troponin I have so many phosphorylation sites? Fact and fancy

Journal of Molecular and Cellular Cardiology

Volumn 48, Issue 5, 2010, Pages 810-816

  Solaro, R John ^a   van der Velden, Jolanda ^b  

^a UNIVERSITY OF ILLINOIS   (United States)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Contractility; Heart; Kinases; Phosphatases; Thin filament

Indexed keywords

CALCIUM ION; REGULATOR PROTEIN; SERINE; TROPONIN I;

DISEASE MODEL; GENETIC DISORDER; HEART DISEASE; HEART FAILURE; HEART FUNCTION; HEART MUSCLE CELL; HUMAN; IN VITRO STUDY; MYOFILAMENT; NONHUMAN; NOTE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN MODIFICATION; PROTEIN PHOSPHORYLATION; PROTEOMICS; SARCOMERE;

ANIMALS; HUMANS; MODELS, BIOLOGICAL; MYOCARDIUM; PHOSPHORIC MONOESTER HYDROLASES; PHOSPHORYLATION; TROPONIN I;

MAMMALIA; RATTUS;

EID: 77951529849     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2010.02.014     Document Type: Note

References (68)

1. Stull J.T., Brostrom C.O., Krebs E.G. Phosphorylation of the inhibitor component of troponin by phosphorylase kinase. J Biol Chem Aug 25 1972, 247(16):5272-5274.
2. Pratje E., Heilmeyer L.M. Phosphorylation of rabbit muscle troponin and actin by a 3′, 5′-c-AMP-dependent protein kinase. FEBS Lett Oct 15 1972, 27(1):89-93.
3. Metzger J.M., Westfall M.V. Covalent and noncovalent modification of thin filament action: the essential role of troponin in cardiac muscle regulation. Circ Res Feb 6 2004, 94(2):146-158.
4. Kobayashi T., Solaro R.J. Calcium, thin filaments, and the integrative biology of cardiac contractility. Annu Rev Physiol 2005, 67:39-67.
5. Solaro R.J., Moir A.J., Perry S.V. Phosphorylation of troponin I and the inotropic effect of adrenaline in the perfused rabbit heart. Nature Aug 12 1976, 262(5569):615-617.
6. Moir A.J., Solaro R.J., Perry S.V. The site of phosphorylation of troponin I in the perfused rabbit heart. The effect of adrenaline. Biochem J Feb 1 1980, 185(2):505-513.
7. Robertson S.P., Johnson J.D., Holroyde M.J., Kranias E.G., Potter J.D., Solaro R.J. The effect of troponin I phosphorylation on the Ca2+-binding properties of the Ca2+-regulatory site of bovine cardiac troponin. J Biol Chem Jan 10 1982, 257(1):260-263.
8. Takimoto E., Soergel D.G., Janssen P.M., Stull L.B., Kass D.A., Murphy A.M. Frequency- and afterload-dependent cardiac modulation in vivo by troponin I with constitutively active protein kinase A phosphorylation sites. Circ Res Mar 5 2004, 94(4):496-504.
9. Moir A.J., Perry S.V. Phosphorylation of rabbit cardiac-muscle troponin I by phosphorylase kinase. The effect of adrenaline. Biochem J Nov 1 1980, 191(2):547-554.
10. Li M.X., Wang X., Lindhout D.A., Buscemi N., Van Eyk J.E., Sykes B.D. Phosphorylation and mutation of human cardiac troponin I deferentially destabilize the interaction of the functional regions of troponin I with troponin C. Biochemistry Dec 16 2003, 42(49):14460-14468.
11. Ke Y., Wang L., Pyle W.G., de Tombe P.P., Solaro R.J. Intracellular localization and functional effects of P21-activated kinase-1 (Pak1) in cardiac myocytes. Circ Res Feb 6 2004, 94(2):194-200.
12. You B., Yan G., Zhang Z., Yan L., Li J., Ge Q., et al. Phosphorylation of cardiac troponin I by mammalian sterile 20-like kinase 1. Biochem J Feb 15 2009, 418(1):93-101.
13. Noland T.A., Raynor R.L., Jideama N.M., Guo X., Kazanietz M.G., Blumberg P.M., et al. Differential regulation of cardiac actomyosin S-1 MgATPase by protein kinase C isozyme-specific phosphorylation of specific sites in cardiac troponin I and its phosphorylation site mutants. Biochemistry Nov 26 1996, 35(47):14923-14931.
14. Noland T.A., Guo X., Raynor R.L., Jideama N.M., Averyhart-Fullard V., Solaro R.J., et al. Cardiac troponin I mutants. Phosphorylation by protein kinases C and A and regulation of Ca(2+)-stimulated MgATPase of reconstituted actomyosin S-1. J Biol Chem Oct 27 1995, 270(43):25445-25454.
15. Mazzei G.J., Kuo J.F. Phosphorylation of skeletal-muscle troponin I and troponin T by phospholipid-sensitive Ca2+-dependent protein kinase and its inhibition by troponin C and tropomyosin. Biochem J Mar 1 1984, 218(2):361-369.
16. Noland T.A., Raynor R.L., Kuo J.F. Identification of sites phosphorylated in bovine cardiac troponin I and troponin T by protein kinase C and comparative substrate activity of synthetic peptides containing the phosphorylation sites. J Biol Chem Dec 5 1989, 264(34):20778-20785.
17. Sumandea M.P., Rybin V.O., Hinken A.C., Wang C., Kobayashi T., Harleton E., et al. Tyrosine phosphorylation modifies protein kinase C delta-dependent phosphorylation of cardiac troponin I. J Biol Chem Aug 15 2008, 283(33):22680-22689.
18. Mathur M.C., Kobayashi T., Chalovich J.M. Negative charges at protein kinase C sites of troponin I stabilize the inactive state of actin. Biophys J Jan 15 2008, 94(2):542-549.
19. Burkart E.M., Sumandea M.P., Kobayashi T., Nili M., Martin A.F., Homsher E., et al. Phosphorylation or glutamic acid substitution at protein kinase C sites on cardiac troponin I differentially depress myofilament tension and shortening velocity. J Biol Chem Mar 28 2003, 278(13):11265-11272.
20. Wang H., Grant J.E., Doede C.M., Sadayappan S., Robbins J., Walker J.W. PKC-betaII sensitizes cardiac myofilaments to Ca2+ by phosphorylating troponin I on threonine-144. J Mol Cell Cardiol Nov 2006, 41(5):823-833.
21. Pi Y., Zhang D., Kemnitz K.R., Wang H., Walker J.W. Protein kinase C and A sites on troponin I regulate myofilament Ca2+ sensitivity and ATPase activity in the mouse myocardium. J Physiol Nov 1 2003, 552(Pt 3):845-857.
22. Pi Y., Kemnitz K.R., Zhang D., Kranias E.G., Walker J.W. Phosphorylation of troponin I controls cardiac twitch dynamics: evidence from phosphorylation site mutants expressed on a troponin I-null background in mice. Circ Res Apr 5 2002, 90(6):649-656.
23. Goldspink P.H., Montgomery D.E., Walker L.A., Urboniene D., McKinney R.D., Geenen D.L., et al. Protein kinase Cepsilon overexpression alters myofilament properties and composition during the progression of heart failure. Circ Res Aug 20 2004, 95(4):424-432.
24. Scruggs S.B., Walker L.A., Lyu T., Geenen D.L., Solaro R.J., Buttrick P.M., et al. Partial replacement of cardiac troponin I with a non-phosphorylatable mutant at serines 43/45 attenuates the contractile dysfunction associated with PKC epsilon phosphorylation. J Mol Cell Cardiol 2006, 40(4):465-473.
25. Sakthivel S., Finley N.L., Rosevear P.R., Lorenz J.N., Gulick J., Kim S., et al. In vivo and in vitro analysis of cardiac troponin I phosphorylation. J Biol Chem Jan 7 2005, 280(1):703-714.
26. Roman B.B., Goldspink P.H., Spaite E., Urboniene D., McKinney R., Geenen D.L., et al. Inhibition of PKC phosphorylation of cTnI improves cardiac performance in vivo. Am J Physiol Heart Circ Physiol Jun 2004, 286(6):H2089-H2095.
27. Solaro R.J., de Tombe P.P. Review focus series: sarcomeric proteins as key elements in integrated control of cardiac function. Cardiovasc Res 2008, 77(4):616-618.
28. Morimoto S. Sarcomeric proteins and inherited cardiomyopathies. Cardiovasc Res Mar 1 2008, 77(4):659-666.
29. Belin R.J., Sumandea M.P., Allen E.J., Schoenfelt K., Wang H., Solaro R.J., et al. Augmented protein kinase C-alpha-induced myofilament protein phosphorylation contributes to myofilament dysfunction in experimental congestive heart failure. Circ Res Jul 20 2007, 101(2):195-204.
30. Belin R.J., Sumandea M.P., Kobayashi T., Walker L.A., Rundell V.L., Urboniene D., et al. Left ventricular myofilament dysfunction in rat experimental hypertrophy and congestive heart failure. Am J Physiol Heart Circ Physiol Nov 2006, 291(5):H2344-H2353.
31. Marston S.B., de Tombe P.P. Troponin phosphorylation and myofilament Ca2+-sensitivity in heart failure: increased or decreased?. J Mol Cell Cardiol Nov 2008, 45(5):603-607.
32. Zabrouskov V., Ge Y., Schwartz J., Walker J.W. Unraveling molecular complexity of phosphorylated human cardiac troponin I by top down electron capture dissociation/electron transfer dissociation mass spectrometry. Mol Cell Proteomics Oct 2008, 7(10):1838-1849.
33. Ayaz-Guner S., Zhang J., Li L., Walker J.W., Ge Y. In vivo phosphorylation site mapping in mouse cardiac troponin I by high resolution top-down electron capture dissociation mass spectrometry: Ser22/23 are the only sites basally phosphorylated. Biochemistry Jul 28 2009, 48(34):8161-8170.
34. Sancho Solis R., Ge Y., Walker J.W. Single amino acid sequence polymorphisms in rat cardiac troponin revealed by top-down tandem mass spectrometry. J Muscle Res Cell Motil 2008, 29(6-8):203-212.
35. Hamdani N., de Waard M., Messer A.E., Boontje N.M., Kooij V., van Dijk S., et al. Myofilament dysfunction in cardiac disease from mice to men. J Muscle Res Cell Motil 2008, 29(6-8):189-201.
36. Marston S.B., Walker J.W. Back to the future: new techniques show that forgotten phosphorylation sites are present in contractile proteins of the heart whilst intensively studied sites appear to be absent. J Muscle Res Cell Motil 2009, 30:93-95.
37. Kooij V., Boontje N., Zaremba R., Jaquet K., Dos Remedios C., Stienen G.J., et al. Protein kinase C alpha and epsilon phosphorylation of troponin and myosin binding protein C reduce Ca(2+) sensitivity in human myocardium. Basic Res Cardiol Aug 5 2010, 105(2):289-300.
38. Kaminsky M., Afari-Armah N., Dike U., Solaro R.J., Chen-Izu Y., Sumandea M.P. Differential phosphorylation of cTnT, cTnI and MLC2 with heart disease progression from pre-hypertension to heart failure. Biophys J 2005, 153/PosB528.
39. McDonough J.L., Labugger R., Pickett W., Tse M.Y., MacKenzie S., Pang S.C., et al. Cardiac troponin I is modified in the myocardium of bypass patients. Circulation Jan 2 2001, 103(1):58-64.
40. Murphy A.M., Kogler H., Georgakopoulos D., McDonough J.L., Kass D.A., Van Eyk J.E., et al. Transgenic mouse model of stunned myocardium. Science Jan 21 2000, 287(5452):488-491.
41. Feng J., Schaus B.J., Fallavollita J.A., Lee T.C., Canty J.M. Preload induces troponin I degradation independently of myocardial ischemia. Circulation Apr 24 2001, 103(16):2035-2037.
42. Gao W.D., Atar D., Liu Y., Perez N.G., Murphy A.M., Marban E. Role of troponin I proteolysis in the pathogenesis of stunned myocardium. Circ Res Mar 1997, 80(3):393-399.
43. McDonough J.L., Arrell D.K., Van Eyk J.E. Troponin I degradation and covalent complex formation accompanies myocardial ischemia/reperfusion injury. Circ Res Jan 8-22 1999, 84(1):9-20.
44. Van Eyk J.E., Powers F., Law W., Larue C., Hodges R.S., Solaro R.J. Breakdown and release of myofilament proteins during ischemia and ischemia/reperfusion in rat hearts: identification of degradation products and effects on the pCa-force relation. Circ Res Feb 9 1998, 82(2):261-271.
45. Tachampa K., Kobayashi T., Wang H., Martin A.F., Biesiadecki B.J., Solaro R.J., et al. Increased cross-bridge cycling kinetics after exchange of C-terminal truncated troponin I in skinned rat cardiac muscle. J Biol Chem May 30 2008, 283(22):15114-15121.
46. Narolska N.A., Piroddi N., Belus A., Boontje N.M., Scellini B., Deppermann S., et al. Impaired diastolic function after exchange of endogenous troponin I with C-terminal truncated troponin I in human cardiac muscle. Circ Res Oct 27 2006, 99(9):1012-1020.
47. Galinska-Rakoczy A., Engel P., Xu C., Jung H., Craig R., Tobacman L.S., et al. Structural basis for the regulation of muscle contraction by troponin and tropomyosin. J Mol Biol Jun 20 2008, 379(5):929-935.
48. Galinska-Rakoczy A., Hatch V., Craig R., Murphy A.M., Van Eyk J.E., Wang C.L.A., et al. EM and 3D-reconstruction of thin filaments reconstituted with truncated troponin I. Biophys J 2009, 96:502a.
49. de Waard M.C., van der Velden J., Bito V., Ozdemir S., Biesmans L., Boontje N.M., et al. Early exercise training normalizes myofilament function and attenuates left ventricular pump dysfunction in mice with a large myocardial infarction. Circ Res Apr 13 2007, 100(7):1079-1088.
50. Duncker D.J., Boontje N.M., Merkus D., Versteilen A., Krysiak J., Mearini G., et al. Prevention of myofilament dysfunction by beta-blocker therapy in postinfarct remodeling. Circ Heart Fail May 2009, 2(3):233-242.
51. Montgomery D.E., Chandra M., Huang Q., Jin J., Solaro R.J. Transgenic incorporation of skeletal TnT into cardiac myofilaments blunts PKC-mediated depression of force. Am J Physiol Heart Circ Physiol Mar 2001, 280(3):H1011-H1018.
52. Sumandea M.P., Pyle W.G., Kobayashi T., de Tombe P.P., Solaro R.J. Identification of a functionally critical protein kinase C phosphorylation residue of cardiac troponin T. J Biol Chem Sep 12 2003, 278(37):35135-35144.
53. Noguchi T., Hunlich M., Camp P.C., Begin K.J., El-Zaru M., Patten R., et al. Thin-filament-based modulation of contractile performance in human heart failure. Circulation Aug 24 2004, 110(8):982-987.
54. Colantonio D.A., Van Eyk J.E., Przyklenk K. Stunned peri-infarct canine myocardium is characterized by degradation of troponin T, not troponin I. Cardiovasc Res Aug 1 2004, 63(2):217-225.
55. van der Velden J., Narolska N.A., Lamberts R.R., Boontje N.M., Borbely A., Zaremba R., et al. Functional effects of protein kinase C-mediated myofilament phosphorylation in human myocardium. Cardiovasc Res Mar 1 2006, 69(4):876-887.
56. Messer A.E., Jacques A.M., Marston S.B. Troponin phosphorylation and regulatory function in human heart muscle: dephosphorylation of Ser23/24 on troponin I could account for the contractile defect in end-stage heart failure. J Mol Cell Cardiol Jan 2007, 42(1):247-259.
57. Wolff M.R., Buck S.H., Stoker S.W., Greaser M.L., Mentzer R.M. Myofibrillar calcium sensitivity of isometric tension is increased in human dilated cardiomyopathies: role of altered beta-adrenergically mediated protein phosphorylation. J Clin Invest Jul 1 1996, 98(1):167-176.
58. Walker L.A., Walker J.S., Ambler S.K., Buttrick P.M. Stage-specific changes in myofilament protein phosphorylation following myocardial infarction in mice. J Mol Cell Cardiol Sep 30 2009.
59. Lamberts R.R., Hamdani N., Soekhoe T.W., Boontje N.M., Zaremba R., Walker L.A., et al. Frequency-dependent myofilament Ca2+ desensitization in failing rat myocardium. J Physiol Jul 15 2007, 582(Pt 2):695-709.
60. Varian K.D., Kijtawornrat A., Gupta S.C., Torres C.A., Monasky M.M., Hiranandani N., et al. Impairment of diastolic function by lack of frequency-dependent myofilament desensitization rabbit right ventricular hypertrophy. Circ Heart Fail Sep 2009, 2(5):472-481.
61. van Heerebeek L., Borbely A., Niessen H.W., Bronzwaer J.G., van der Velden J., Stienen G.J., et al. Myocardial structure and function differ in systolic and diastolic heart failure. Circulation Apr 25 2006, 113(16):1966-1973.
62. Borbely A., Falcao-Pires I., van Heerebeek L., Hamdani N., Edes I., Gavina C., et al. Hypophosphorylation of the Stiff N2B titin isoform raises cardiomyocyte resting tension in failing human myocardium. Circ Res Mar 27 2009, 104(6):780-786.
63. van Dijk S.J., Dooijes D., dos Remedios C., Michels M., Lamers J.M., Winegrad S., et al. Cardiac myosin-binding protein C mutations and hypertrophic cardiomyopathy: haploinsufficiency, deranged phosphorylation, and cardiomyocyte dysfunction. Circulation Mar 24 2009, 119(11):1473-1483.
64. Kooij V., van der Velden J., Stienen G. Effect fo troponin I Ser23/24 bis-phosphorylation on Ca-sensitivity is dependent on PKA phosphorylation of other contractile proteins. Biophys J 2009, 96:501a-502a.
65. Kirk J.A., Macgowan G.A., Evans C., Smith S.H., Warren C.M., Mamidi R., et al. Left ventricular and myocardial function in mice expressing constitutively pseudophosphorylated cardiac troponin I. Circ Res Oct 22 2009, 105(12):1232-1239.
66. Rudy Y., Ackerman M.J., Bers D.M., Clancy C.E., Houser S.R., London B., et al. Systems approach to understanding electromechanical activity in the human heart: a national heart, lung, and blood institute workshop summary. Circulation Sep 9 2008, 118(11):1202-1211.
67. Borbely A., van der Velden J., Papp Z., Bronzwaer J.G., Edes I., Stienen G.J., et al. Cardiomyocyte stiffness in diastolic heart failure. Circulation Feb 15 2005, 111(6):774-781.
68. Freund C., Davis R.P., Gkatzis K., Ward-van Oosterwaard D., Mummery C.L. The first reported generation of human induced pluripotent stem cells (iPS cells) and iPS cell-derived cardiomyocytes in the Netherlands. Neth Heart J Jan 2010, 18(1):51-54.